, The new bone biology: Pathologic, molecular, and clinical correlates, American Journal of Medical Genetics Part A, vol.97, issue.2, pp.2646-2706, 2006.
DOI : 10.1002/ajmg.a.31368
, A case of amelogenesis imperfecta, cleft lip and palate and polycystic kidney disease, Orthodontics and Craniofacial Research, vol.266, issue.1, pp.52-56, 2006.
DOI : 10.1016/S0378-1119(96)00525-2
, Msx2 ?/? transgenic mice develop compound amelogenesis imperfecta, dentinogenesis imperfecta and periodental osteopetrosis, Bone, vol.41, issue.5, pp.851-859, 2007.
DOI : 10.1016/j.bone.2007.07.023
, Osteoclasts in the Dental Microenvironment: A Delicate Balance Controls Dental Histogenesis, Cells Tissues Organs, vol.194, issue.2-4, pp.2-4, 2011.
DOI : 10.1159/000324787
, Enamel Protein Regulation and Dental and Periodontal Physiopathology in Msx2 Mutant Mice, The American Journal of Pathology, vol.177, issue.5, pp.2516-2526, 2010.
DOI : 10.2353/ajpath.2010.091224
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966808
, Progressive increase in bone mass and development of odontomas in aging osteopetrotic c-src-deficient mice, Bone, vol.27, issue.5, pp.603-610, 2000.
DOI : 10.1016/S8756-3282(00)00373-2
, with odontoma-like proliferations and lack of tooth roots, European Journal of Oral Sciences, vol.72, issue.6, pp.625-635, 2009.
DOI : 10.1111/j.1600-0722.2009.00690.x
, Receptor activator of NF-?B (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit, Proceedings of the National Academy of Sciences, vol.99, issue.13, pp.5342-5347, 2011.
DOI : 10.1073/pnas.132636999
URL : https://hal.archives-ouvertes.fr/hal-00579674
, Bone resorption control of tooth eruption and root morphogenesis: Involvement of the receptor activator of NF-?B (RANK), Journal of Cellular Physiology, vol.228, issue.1, pp.74-85, 2011.
DOI : 10.1002/jcp.22305
, Comparative Study of MSX-2, DLX-5, and DLX-7 Gene Expression during Early Human Tooth Development, Pediatric Research, vol.17, issue.6, pp.650-656, 1999.
DOI : 10.1203/00006450-199912000-00015
, Physiological implications of DLX homeoproteins in enamel formation, Journal of Cellular Physiology, vol.275, issue.90, pp.688-697, 2008.
DOI : 10.1002/jcp.21448
, Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2, Nucleic Acids Research, vol.34, issue.20, pp.5951-5965, 2006.
DOI : 10.1093/nar/gkl689
URL : http://doi.org/10.1093/nar/gkl689
, Crosstalk between cancer cells and bone microenvironment in bone metastasis, Biochemical and Biophysical Research Communications, vol.328, issue.3, pp.679-687, 2005.
DOI : 10.1016/j.bbrc.2004.11.070
, The human homeobox genes MSX-1, MSX-2, and MOX-1 are differentially expressed in the dermis and epidermis in fetal and adult skin, Differentiation, vol.62, issue.1, pp.33-41, 1997.
DOI : 10.1046/j.1432-0436.1997.6210033.x
, Functional and prognostic relevance of the homeobox protein MSX2 in malignant melanoma, British Journal of Cancer, vol.125, issue.4, pp.565-574, 2011.
DOI : 10.1128/JVI.77.16.8957-8951.2003
, Nasal inverted papilloma expresses the muscle segment homeobox gene Msx2: possible prognostic implications, Human Pathology, vol.39, issue.3, pp.350-358, 2008.
DOI : 10.1016/j.humpath.2007.06.017
, Msx and Dlx Homeogene Expression in Epithelial Odontogenic Tumors, Journal of Histochemistry & Cytochemistry, vol.210, issue.1, pp.69-78, 2009.
DOI : 10.1111/j.1601-0825.2005.01177.x
, The role of RANKL and MMP-9 in the bone resorption caused by ameloblastoma, Journal of Oral Pathology & Medicine, vol.203, issue.Suppl. 1, pp.592-598, 2010.
DOI : 10.1111/j.1600-0714.2009.00882.x
, Trafficking of Natural Killer Cells, Current Molecular Medicine, vol.4, issue.4, pp.431-438, 2004.
DOI : 10.2174/1566524043360609
, Monocytes control natural killer cell differentiation to effector phenotypes, Blood, vol.117, issue.17, pp.4511-4518, 2011.
DOI : 10.1182/blood-2010-10-312264
, Inflammatory bone loss: pathogenesis and therapeutic intervention, Nature Reviews Drug Discovery, vol.26, issue.3, pp.234-250, 2012.
DOI : 10.1038/nrd3669
, Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12, Histochemistry and Cell Biology, vol.120, issue.5, pp.391-400, 2003.
DOI : 10.1007/s00418-003-0587-3
, Protumoral role of monocytes in human B-cell precursor acute lymphoblastic leukemia: involvement of the chemokine CXCL10, Blood, vol.119, issue.1, pp.227-237, 2012.
DOI : 10.1182/blood-2011-06-357442
, Reciprocal cross-talk between RANKL and interferon-??inducible protein 10 is responsible for bone-erosive experimental arthritis, Arthritis & Rheumatism, vol.44, issue.5, pp.1332-1342, 2008.
DOI : 10.1002/art.23372
, An in vivo genome wide gene expression study of circulating monocytes suggested GBP1, STAT1 and CXCL10 as novel risk genes for the differentiation of peak bone mass, Bone, vol.44, issue.5, pp.1010-1014, 2009.
DOI : 10.1016/j.bone.2008.05.016
, Interferon-? and -? differentially regulate osteoclastogenesis: Role of differential induction of chemokine CXCL11 expression, Proceedings of the National Academy of Sciences, vol.1704, issue.2, pp.11917-11922, 2005.
DOI : 10.1172/JCI9232
, Pharmacological Characterization of CXC Chemokine Receptor 3 Ligands and a Small Molecule Antagonist, Journal of Pharmacology and Experimental Therapeutics, vol.313, issue.3, pp.1263-1271, 2005.
DOI : 10.1124/jpet.105.083683